The Patterson Analysis

Half of U.S. shoppers now fear artificial ingredients, a new study finds. This is fueling a massive push for cleaner labels and stricter safety laws.

PGA star Max Homa shares his hidden health battle with seborrheic dermatitis, urging millions to trade self-diagnosis for a doctor's visit.

The partnership moves beyond compliance, integrating deep binary analysis with lifecycle management to provide continuous software risk intelligence for critical industries.

Target Hospitality is rapidly expanding workforce housing for AI data centers, revealing the massive, unseen physical infrastructure powering the tech revolution.

A new report shows patients are rejecting 'overdone' looks for subtle, strategic care, driven by Ozempic, menopause, and a desire for authenticity.

The company's revenue skyrocketed, but SEC filings reveal a story of significant liquidity risks and a bold gamble on the booming wellness market.

US-based FTC Solar secures a major three-year supply agreement in South Africa, poised to energize the nation's grid amid a critical power crisis.

Montreal firm's advanced titanium powder will fuel next-gen aerospace innovation, highlighting its role in a critical, high-growth global market.

A 14th-century Scottish castle is set for a modern makeover as MDJM LTD bets on turning the historic Fernie Castle into a major animation art gallery.

With its acquisition of Turner Software, Finovifi launches FrontLine Sentry, arming community banks with real-time AI to stop check fraud at the source.

Bitdeer leverages complex financial deals to refinance debt and fund a major expansion into the booming AI and high-performance computing market.

A new investment aims to bolster NYC's grid with battery storage, but developers face a charged debate between climate goals and community safety fears.

A renewed partnership between the world's largest yacht marketplace and a top European dealer highlights how trust and tech are reshaping the superyacht market.

Element Biosciences unveils VITARI, a high-throughput benchtop sequencer promising a $100 whole genome, challenging market giants and democratizing genomics.

Travelzoo's Q4 revenue grew 9%, but profits evaporated as it invests heavily in its new subscription model. Is this a winning long-term strategy?

With COVID revenue fading, QuidelOrtho will use a key conference to prove its diversified diagnostics model can deliver on growth, margins, and cash flow.

Tufin promotes Dan Hatch to SVP of Global Sales, signaling a major push to expand its AI-driven security solutions and subscription-based model.

AVEO Oncology's ficlatuzumab advances in a pivotal Phase 3 trial, offering new hope for patients with a difficult-to-treat form of head and neck cancer.

A new US-designed and assembled O-RAN radio marks a major step in America's push for a secure, domestic 5G supply chain, fueled by NTIA funding.

Photocure reports robust Q4 earnings and a strong 2026 forecast, while pivoting to an AI-driven future for bladder cancer diagnostics and global expansion.